{"transactions":[{"id":780690,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-13T12:47:13.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on May 8, 2026. The 25% of the shares underlying the option are scheduled to vest on May 8, 2027 and thereafter in equal monthly installments through May 8, 2031."}],"balance_after":150000,"derivative":{"exercise_price":1.17,"expiration_date":"2036-05-08","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193125-26-220718","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526220718/ownership.xml","form_type":"4"}},{"id":780689,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-13T12:47:13.000Z","date":"2026-04-30","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased in Issuer's April 30, 2026 follow-on public offering."}],"balance_after":27046,"source":{"system":"sec-edgar","filing":"0001193125-26-220718","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526220718/ownership.xml","form_type":"4"}},{"id":1338879,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-09T21:09:30.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":161,"price":2.25,"value":362.25,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":161,"source":{"system":"sec-edgar","filing":"0000950170-24-134522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134522/ownership.xml","form_type":"4"}},{"id":1338878,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-12-09T21:09:30.000Z","date":"2024-12-05","kind":"purchase","planned":false,"acquired":true,"shares":239,"price":2.24,"value":535.36,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":239,"source":{"system":"sec-edgar","filing":"0000950170-24-134522","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024134522/ownership.xml","form_type":"4"}},{"id":1342765,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-04T21:05:08.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":517500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest as of 25% of the shares on December 2, 2025 and thereafter in equal monthly installments through December 2, 2028."}],"balance_after":517500,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":517500},"source":{"system":"sec-edgar","filing":"0000950170-24-133231","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024133231/ownership.xml","form_type":"4"}},{"id":1591408,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Series X Non-Voting Convertible Preferred","published_at":"2024-03-06T22:06:15.000Z","date":"2024-03-05","kind":"exercise","planned":false,"acquired":false,"shares":2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000950170-24-027304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024027304/ownership.xml","form_type":"4"}},{"id":1591407,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2024-03-06T22:06:15.000Z","date":"2024-03-05","kind":"exercise","planned":false,"acquired":true,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 5, 2024, the Issuer's outstanding Series X Non-Voting Convertible Preferred Stock, par value $0.001 per share (\"Series X Preferred Stock\") automatically converted into shares of common stock of the Issuer, par value $0.001 per share (\"Common Stock\"), subject to certain beneficial ownership limitations. By operation of the certificate of designation for the Series X Preferred Stock, each share of Series X Preferred Stock was converted into 1,000 shares of Common Stock for no consideration."}],"balance_after":7122,"source":{"system":"sec-edgar","filing":"0000950170-24-027304","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017024027304/ownership.xml","form_type":"4"}},{"id":1706993,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-12-18T22:56:31.000Z","date":"2023-12-15","kind":"purchase","planned":false,"acquired":true,"shares":225,"price":3.37,"value":758.25,"ownership":{"direct":false,"nature":"By son"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose"}],"balance_after":225,"source":{"system":"sec-edgar","filing":"0000950170-23-071200","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017023071200/ownership.xml","form_type":"4"}},{"id":1732496,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2023-11-21T21:43:12.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":5076,"price":1.9675,"value":9987.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.965 - $1.9699. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5122,"source":{"system":"sec-edgar","filing":"0000950170-23-065545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1420565/000095017023065545/ownership.xml","form_type":"4"}},{"id":2951088,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-12-09T16:30:29.000Z","date":"2020-12-07","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"18,003 shares of common stock vested on September 26, 2019 and the remainder of the shares vested at an approximate rate of 4,500 every three months thereafter."}],"balance_after":134429,"derivative":{"exercise_price":2.5,"exercise_date":"2019-09-26","expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-20-041813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390020041813/ownership.xml","form_type":"4"}},{"id":2951087,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2020-12-09T16:30:29.000Z","date":"2020-12-07","kind":"sale","acquired":false,"shares":25000,"price":15.8,"value":395000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-20-041813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390020041813/ownership.xml","form_type":"4"}},{"id":2951086,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2020-12-09T16:30:29.000Z","date":"2020-12-07","kind":"exercise","acquired":true,"shares":25000,"price":2.5,"value":62500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001213900-20-041813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390020041813/ownership.xml","form_type":"4"}},{"id":3046020,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-08-26T18:13:47.000Z","date":"2020-08-24","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of\nthe Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Option shall vest and first become exercisable as follows: one-quarter of the Option shall vest and first become exercisable on August 24, 2021 and the remainder of\nthe Option shall vest and first become exercisable in 12 equal quarterly installments commencing on November 24, 2021."}],"balance_after":159429,"derivative":{"exercise_price":13.65,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-20-023891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390020023891/ownership.xml","form_type":"4"}},{"id":3353597,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-12-03T19:44:41.000Z","date":"2019-11-29","kind":"grant","acquired":true,"shares":3623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years."}],"balance_after":139429,"derivative":{"exercise_price":5,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":3623},"source":{"system":"sec-edgar","filing":"0001213900-19-025253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390019025253/ownership.xml","form_type":"4"}},{"id":3386066,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-10-29T20:35:23.000Z","date":"2019-10-29","kind":"grant","acquired":true,"shares":43794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years."}],"balance_after":135806,"derivative":{"exercise_price":5,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":43794},"source":{"system":"sec-edgar","filing":"0001213900-19-021428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390019021428/ownership.xml","form_type":"4"}},{"id":3386065,"issuer":{"id":89110,"kind":"organization","name":"TFF Pharmaceuticals, Inc.","symbol":"TFFP"},"owners":[{"id":47645,"kind":"person","name":"WINDSOR JAMES BRIAN","position":1,"cik":"0001790933","reported_name":"WINDSOR JAMES BRIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2019-10-29T20:35:23.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":5000,"price":5,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock purchased in the Issuer's initial public offering."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-19-021428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733413/000121390019021428/ownership.xml","form_type":"4"}}]}